- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Hemochromatosis.
Displaying page 1 of 1.
EudraCT Number: 2008-000360-16 | Sponsor Protocol Number: P030 | Start Date*: 2009-08-06 | ||||||||||||||||
Sponsor Name:Medizinische Universität Innsbruck, Innere Medizin I | ||||||||||||||||||
Full Title: EFFECTS OF NIFEDIPINE ON IRON HOMEOSTASIS IN PATIENTS SUFFERING FROM IRONOVERLOAD DISEASES - Effekte von Nifedipin auf die Eisenhomeostase bei Patienten mit Eisenüberladungsstörungen | ||||||||||||||||||
Medical condition: Hämochromatose ist eine Gruppe genetischer Erkrankungen (Mutationen) denen eine erhöhte Transferrinsättigung und Ferritinspiegel im Blut und Eisenablagerung in Organen, vor allem Leber, Bauchspeich... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-002102-57 | Sponsor Protocol Number: CICL670A2202 | Start Date*: 2006-10-12 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A phase I/II open label, dose escalation trial to explore the safety and efficacy of ICL670 in patients with iron overload resulting from hereditary hemochromatosis | |||||||||||||
Medical condition: hereditary hemochromatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002099-16 | Sponsor Protocol Number: 06/Q0703/56 | Start Date*: 2006-07-13 | |||||||||||
Sponsor Name:King's College London | |||||||||||||
Full Title: The effect of milk thistle extract (Legalon) versus tea on serum iron increase after a meal containing non-haem iron in hereditary haemochromatosis | |||||||||||||
Medical condition: Type 1 hereditary haemochromatosis is associated with homozygous inheritance of the C282Y mutation in the HFE gene. The phenotype is characterised by increased serum iron levels, tissue iron accumu... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002529-12 | Sponsor Protocol Number: CICL670F2203 | Start Date*: 2017-10-19 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: A phase II, multicenter, open-label, randomized two-year study to evaluate the efficacy and safety of deferasirox film-coated tablet versus phlebotomy in patients with Hereditary Hemochromatosis | |||||||||||||
Medical condition: Hereditary Hemochromatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) SK (Completed) DE (Completed) BE (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000603-32 | Sponsor Protocol Number: NL3364409612 | Start Date*: 2012-08-27 |
Sponsor Name:Annadalstichting | ||
Full Title: Proton pump inhibitors in the prevention of iron reaccumulation in patients with hereditary hemochromatosis | ||
Medical condition: Hereditary hemochromatosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003598-33 | Sponsor Protocol Number: LJ401-HH01 | Start Date*: 2018-04-03 | |||||||||||
Sponsor Name:La Jolla Pharmaceutical Company | |||||||||||||
Full Title: A Phase 2, Multi-center, Randomized, Placebo-controlled, Single-blind Study with LJPC-401 for the Treatment of Iron Overload in Adult Patients with Hereditary Hemochromatosis | |||||||||||||
Medical condition: Hereditary Hemochromatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003777-34 | Sponsor Protocol Number: NL63198.041.17 | Start Date*: 2018-02-09 | |||||||||||||||||||||||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||||||||||||||||||||||
Full Title: Proton pump inhibition for secondary hemochromatosis in hereditary anemia, a phase III placebo controlled randomized cross-over clinical trial. | |||||||||||||||||||||||||||||||||
Medical condition: Iron overload (secondary hemochromatosis) in non-transfusion dependent forms of hereditary anemias. Iron overload and hereditary anemia are a growing, underestimated emerging health care problem. | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-003074-26 | Sponsor Protocol Number: EPC/02 | Start Date*: 2007-06-20 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: Oral iron challange on urinary excretion of hepcidin, the key iron regulatory hormone in hemochromatosis. | |||||||||||||
Medical condition: Treatment of hereditary emocromatosis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005089-12 | Sponsor Protocol Number: TRO19622 CL E Q 1159-1 | Start Date*: 2008-02-05 | |||||||||||
Sponsor Name:TROPHOS | |||||||||||||
Full Title: Study title: Double-blind vs Placebo, Randomized, Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 500 mg QD for One Month in Patients with Non-Alcoholi... | |||||||||||||
Medical condition: - Non Alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001979-70 | Sponsor Protocol Number: IVA_01_337_HNAS_16_002 | Start Date*: 2017-01-23 | |||||||||||
Sponsor Name:Inventiva S.A. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) AT (Completed) PT (Completed) ES (Completed) NL (Completed) PL (Completed) FR (Completed) BG (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021963-34 | Sponsor Protocol Number: 2125-202 | Start Date*: 2010-11-03 | |||||||||||
Sponsor Name:Idera Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Comparator-Controlled, 12-week Trial of IMO-2125 plus Ribavirin in Patients Infected with Hepatitis C Virus who were Nonresponders to Pegylated-Interferon plus ... | |||||||||||||
Medical condition: This is a Phase 2, randomized, double-blind, comparator-controlled study of IMO-2125 in hepatitis C-infected patients who were previously nonresponders to standard treatment (pegylated-interferon p... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
